$ICPT INTERCEPT PHARMACEUTICALS, INC. Insider Trading Week 18/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. in week 18/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Option Exercise | M | 0.00 | 325 | 0 | 324 | |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Buy | M | 0.00 | 325 | 0 | 2,629 | 2.3 K to 2.6 K (+14.11 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Option Exercise | M | 0.00 | 325 | 0 | 324 | |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Sell | S | 232.00 | 325 | 75,400 | 1,655 | 2 K to 1.7 K (-16.41 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Buy | M | 0.00 | 325 | 0 | 1,980 | 1.7 K to 2 K (+19.64 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Option Exercise | M | 0.00 | 367 | 0 | 368 | |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Buy | M | 0.00 | 367 | 0 | 3,304 | 2.9 K to 3.3 K (+12.50 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Option Exercise | M | 0.00 | 325 | 0 | 324 | |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 232.35 | 100 | 23,235 | 1,780 | 1.9 K to 1.8 K (-5.32 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 228.69 | 62 | 14,179 | 1,880 | 1.9 K to 1.9 K (-3.19 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Buy | M | 0.00 | 325 | 0 | 1,942 | 1.6 K to 1.9 K (+20.10 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 251.25 | 65 | 16,331 | 1,617 | 1.7 K to 1.6 K (-3.86 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 250.46 | 100 | 25,046 | 1,682 | 1.8 K to 1.7 K (-5.61 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 252.31 | 100 | 25,231 | 1,782 | 1.9 K to 1.8 K (-5.31 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 255.91 | 100 | 25,591 | 1,882 | 2 K to 1.9 K (-5.05 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 254.00 | 100 | 25,400 | 1,982 | 2.1 K to 2 K (-4.80 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 254.09 | 100 | 25,409 | 2,082 | 2.2 K to 2.1 K (-4.58 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 261.42 | 100 | 26,142 | 2,182 | 2.3 K to 2.2 K (-4.38 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | TALLARIGO LORENZO | Director | Option Exercise | M | 0.00 | 367 | 0 | 368 | |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | TALLARIGO LORENZO | Director | Sell | S | 232.00 | 367 | 85,144 | 0 | 367 to 0 (-100.00 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | TALLARIGO LORENZO | Director | Buy | M | 0.00 | 367 | 0 | 367 | 0 to 367 |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | TALLARIGO LORENZO | Director | Sell | S | 260.76 | 1,000 | 260,760 | 0 | 1,000 to 0 (-100.00 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | TALLARIGO LORENZO | Director | Sell | S | 258.20 | 640 | 165,248 | 1,000 | 1.6 K to 1,000 (-39.02 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Option Exercise | M | 10.40 | 2,000 | 20,800 | 0 | |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 260.76 | 1,000 | 260,760 | 7,464 | 8.5 K to 7.5 K (-11.81 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 258.12 | 1,000 | 258,115 | 8,464 | 9.5 K to 8.5 K (-10.57 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Buy | M | 10.40 | 2,000 | 20,800 | 9,464 | 7.5 K to 9.5 K (+26.80 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | M | 0.00 | 325 | 0 | 324 | |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | M | 0.00 | 1,330 | 0 | 0 | |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Buy | M | 0.00 | 325 | 0 | 1,656,258 | 1.7 M to 1.7 M (+0.02 %) |
May 09 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Buy | M | 0.00 | 1,330 | 0 | 1,655,933 | 1.7 M to 1.7 M (+0.08 %) |